73472-94-3

Basic information

• Product Name: 3-BroMo-2-hydroxy-propionic acid ethyl ester
• Synonyms: 3-BroMo-2-hydroxy-propionic acid ethyl ester;Ethyl 3-Bromo-2-(hydroxyimino)propanoate
• CAS NO: 73472-94-3
• Molecular Formula: C₅H₈BrNO₃
• Molecular Weight: 197.02716
• Mol File: 73472-94-3.mol
• Article Data: 18

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-BroMo-2-hydroxy-propionic acid ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BroMo-2-hydroxy-propionic acid ethyl ester(73472-94-3)
• EPA Substance Registry System: 3-BroMo-2-hydroxy-propionic acid ethyl ester(73472-94-3)

Safety Data

• Hazardous Substances Data: 73472-94-3(Hazardous Substances Data)

Usage

General Description

3-Bromo-2-hydroxy-propionic acid ethyl ester is a chemical compound with the molecular formula C5H9BrO3. It is an ethyl ester of 3-bromo-2-hydroxypropionic acid, and it is often used as a reagent in organic synthesis. 3-BroMo-2-hydroxy-propionic acid ethyl ester has potential applications in pharmaceuticals and agrochemicals due to its unique chemical structure and properties. It is also useful as an intermediate in the production of other chemical compounds. However, it is important to handle this chemical with care, as it can be hazardous if not properly managed and stored.

Upstream product

• 64-17-5 ethanol 
• 1113-59-3 bromopyruvic acid 
• 617-35-6 2-oxo-propionic acid ethyl ester 
• 70-23-5 ethyl Bromopyruvate 
• 5470-11-1 hydroxylamine hydrochloride 

Downstream Products

• 73473-03-7 3-ethoxycarbonyl-4a-methyl-4,4a,9,9a-tetrahydro-1,2-oxazino[6,5-b]indole 
• 73473-16-2 6-methyl-6-phenyl-5,6-dihydro-4H-[1,2]oxazine-3-carboxylic acid 
• 73473-06-0 3-ethoxycarbonyl-6-methyl-6-phenyl-5,6-dihydro-4H-1,2-oxazine 
• 124455-77-2 ethyl 1,4,5,6-tetrahydrocyclopentadieno[b]pyrrole-2-carboxylate 
• 203934-60-5 3-ethoxycarbonyl-2,8-diazaspiro[4.5]decane-8-carboxylic acid tert-butyl ester 
• 73472-96-5 ethyl (2-hydroxyimino)-3-(2-pyrrolyl)propanoate 
• 69687-82-7 5-Ethyl-4-methylpyrrol-2-carbonsaeure-ethylester 
• 73472-99-8 3-Benzylsulfanyl-2-[(E)-hydroxyimino]-propionic acid ethyl ester 
• 1426304-30-4 1,9-bis(2'-ethoxycarbonyl-2’-hydroxyiminoethyl)-5-phenyldipyrromethane 
• 1426304-22-4 1-(2'-ethoxycarbonyl-2'-hydroxyiminoethyl)-5-phenyldipyrromethane 
• 1185251-10-8 ethyl 3-((6-acetylnaphthalen-2-yl)(2,4-dimethoxybenzyl)amino)-2-(hydroxyimino)propanoate 

Relevant articles and documents

Synthesis of some novel tricyclic α-aminoacid esters and potential bioactive compounds via 1,2-prototropy and 1,3-APT cascade reactions

Some novel cyclic α-aminoacid esters and potential bioactive compounds were prepared via thermal 1,2-prototropy- and 1,3-APT oxime nitrone-1,3-dipolar cycloaddition cascades reactions. This substrate allows the influence of the new stereocentres on the cascade to be assessed with respect to the configuration of the nitrone that is generated and the facial selectivity of the subsequent cycloaddition.

Synthesis of sterically encumbered 11β-aminoprogesterone derivatives and evaluation as 11β-hydroxysteroid dehydrogenase inhibitors and mineralocorticoid receptor antagonists

11β-Hydroxyprogesterone is a well-known nonselective inhibitor of 11β-hydroxysteroid dehydrogenase (11βHSD) types 1 and 2. It also activates the mineralocorticoid receptor (MR). Modulation of corticosteroid action by inhibition of 11βHSDs or blocking MR i

KINASE INHIBITOR COMPOUNDS AND COMPOSITIONS AND METHODS OF USE

Described herein are compounds having the following structure: formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof. Also disclosed are compositions containing the compounds, methods of inhibiting activity of DYRKl A in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.

COMPOUNS, COMPOSITIONS AND METHODS OF USE

Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.